Specialty & Blends
Semaglutide (5mg) + BPC-157 (5mg)
Made in the USAA two-component research blend of Semaglutide and BPC-157. Semaglutide is studied for GLP-1 receptor signaling, appetite regulation and glucose metabolism; BPC-157 research examines tissue responses, tendon fibroblasts and repair-related signaling. The formulation brings these distinct research areas into one catalog presentation.
What is it researched for?
Primary research focus: Specialty & Blends. This description is not a medical indication.
Presentations & pricing
5mg/5mg · $190
Request this product
Select a presentation above to update the vial, label and inquiry. The team confirms availability and next steps.
Research information only; this page does not provide dosing, prescribing or treatment instructions. Verify regulatory status and documentation for the applicable product and lot.